Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.26% |
| 2 | Healthcare | 16.99% |
| 3 | Technology | 15.48% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
BHP
BHP
$242B
| $497K | ﹤0.01% |
+19,498
| New | +$486K |
|
|
BSFT
602
DELISTED
BroadSoft, Inc.
BSFT
| $495K | ﹤0.01% |
12,059
-667
| -5% | -$27.5K |
|
603
B&G Foods
BGS
$286M
| $488K | ﹤0.01% |
10,115
-9,962
| -50% | -$406K |
|
604
ArcelorMittal
MT
$56.1B
| $482K | ﹤0.01% |
34,505
+25,574
| +286% | +$389K |
|
|
BHI
605
DELISTED
Baker Hughes
BHI
| $474K | ﹤0.01% |
+10,512
| New | +$476K |
|
606
Insulet
PODD
$10.1B
| $457K | ﹤0.01% |
+15,122
| New | +$470K |
|
|
CSII
607
DELISTED
Cardiovascular Systems, Inc.
CSII
| $456K | ﹤0.01% |
24,795
-21,865
| -47% | -$342K |
|
608
Alcoa
AA
$13.3B
| $454K | ﹤0.01% |
20,363
+15,093
| +286% | +$353K |
|
|
IPHI
609
DELISTED
INPHI CORPORATION
IPHI
| $446K | ﹤0.01% |
13,910
-789
| -5% | -$24.8K |
|
610
Ecolab
ECL
$80.4B
| $433K | ﹤0.01% |
+3,655
| New | +$426K |
|
611
FTI Consulting
FCN
$4.25B
| $429K | ﹤0.01% |
+10,552
| New | +$417K |
|
|
DD
612
DELISTED
Du Pont De Nemours E I
DD
| $417K | ﹤0.01% |
+6,441
| New | +$423K |
|
613
PPG Industries
PPG
$25.4B
| $404K | ﹤0.01% |
+3,883
| New | +$424K |
|
614
Terreno Realty
TRNO
$7.26B
| $377K | ﹤0.01% |
+14,568
| New | +$346K |
|
|
SCAI
615
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $362K | ﹤0.01% |
7,594
-437
| -5% | -$20.2K |
|
|
SGNT
616
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $355K | ﹤0.01% |
+23,728
| New | +$305K |
|
617
iShares Core S&P 500 ETF
IVV
$898B
| $331K | ﹤0.01% |
+1,573
| New | +$328K |
|
618
JD.com
JD
$38.8B
| $311K | ﹤0.01% |
14,628
-13,688,195
| -100% | -$331M |
|
|
ZLTQ
619
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $305K | ﹤0.01% |
11,172
-3,864
| -26% | -$109K |
|
|
ABMD
620
DELISTED
Abiomed Inc
ABMD
| $299K | ﹤0.01% |
2,736
-171
| -6% | -$17K |
|
621
Franco-Nevada
FNV
$51.3B
| $292K | ﹤0.01% |
+3,842
| New | +$260K |
|
622
Zumiez
ZUMZ
$307M
| $292K | ﹤0.01% |
20,432
-10,746
| -34% | -$171K |
|
623
Tandem Diabetes Care
TNDM
$1.49B
| $279K | ﹤0.01% |
3,703
+614
| +20% | +$49.4K |
|
|
WUBA
624
DELISTED
58.com Inc
WUBA
| $277K | ﹤0.01% |
6,034
| – | – |
|
625
Meritage Homes
MTH
$4.63B
| $272K | ﹤0.01% |
14,480
-30,562
| -68% | -$554K |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $5.05B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.